Hui Wang

Hui Wang

Director/Board Member chez VIVA BIOTECH HOLDINGS

Fortune : 30 M $ au 31/03/2024

52 ans
Health Technology
Finance
Consumer Services

Profil

Hui Wang has founded Jiangsu Highlight Equity Investment Management Co. Ltd.
in 2014, where he holds the title of Founding Partner.
He is currently the Chief Executive Officer at Highlight Capital Fund since 2014.
Mr. Wang is also a Director at Suzhou Kintor Pharmaceuticals, Inc., a Non-Executive Director at Viva Biotech Holdings starting in 2024, a Director at Biotheus, Inc., a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd.
since 2020, and a Director at WinnTi Medical Technology (Shanghai) Co., Ltd.
Mr. Wang previously served as a Senior Partner at CDH Venture Partners LP starting in 2009.
He held the position of Vice Chairman at Juva (Tianjin) Medical Technology Co., Ltd.
and Chairman-Supervisory Board at Chengdu Angel Healthcare Holding Co., Ltd.
Mr. Wang was also a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd.
from 2015 to 2018 and a General Partner at CDH Investments from 2009 to 2014.
He has also worked as a Principal at Becton, Dickinson & Co. Mr. Wang received a graduate degree from New York University in 1998, an undergraduate degree from the University of Science & Technology of China in 1996, and an MBA from London Business School in 2007.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/12/2023 24 384 865 ( 7,51% ) 30 M $ 31/03/2024

Postes actifs de Hui Wang

SociétésPosteDébut
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Director/Board Member 28/12/2020
VIVA BIOTECH HOLDINGS Director/Board Member 18/01/2024
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 01/01/2009
Founder 01/01/2014
Chief Executive Officer 01/01/2014
Director/Board Member -
Tous les postes actifs de Hui Wang

Anciens postes connus de Hui Wang

SociétésPosteFin
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Director/Board Member 01/03/2018
░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░ ░░░░░░░░ -
Voir l'expérience en détail de Hui Wang

Formation de Hui Wang

New York University Graduate Degree
University of Science & Technology of China Undergraduate Degree
London Business School Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Hui Wang

Relations

100 +

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
BECTON, DICKINSON AND COMPANY

Health Technology

VIVA BIOTECH HOLDINGS

Health Technology

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Health Technology

Entreprise privées9

Finance

Finance

Finance

Finance

Finance

Distribution Services

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés